share_log

Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.

Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.

炙手可熱的IPOF股票將於10月14日停止交易。原因如下。
InvestorPlace ·  2022/09/20 11:17

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

InvestorPlace-股票市場新聞、股票建議和交易提示

Shares of special purpose acquisition company (SPAC) Social Capital Hedosophia VI (NYSE:IPOF) are falling back to their initial public offering price of $10 after Chamath Palihapitiya announced that he would return all funds to IPOF stock holders.

特殊目的收購公司(SPAC)的股份社會資本HedosophiaVI(紐約證券交易所股票代碼:IPOF)在Chaath Palihapitiya宣佈將把所有資金返還給IPOF股東後,股價回落至10美元的首次公開募股價格。

Palihapitiya explained his team evaluated more than 100 potential targets, but they ultimately stepped away due to two reasons. The first reason was valuation. He noted there were several interesting targets, although a deal "would have required us stretching on price or buying an inferior asset."

Palihapitiya解釋説,他的團隊評估了100多個潛在目標,但他們最終放棄了,原因有兩個。第一個原因是估值。他指出,有幾個令人感興趣的目標,儘管交易“需要我們提高價格或購買劣質資產”。

The second reason was the volatile state of the market. Several company's management teams were hesitant to go public in a downturn year ravaged by inflation, interest rate hikes and supply chain issues.

第二個原因是市場的動盪狀態。在通脹、加息和供應鏈問題肆虐的經濟低迷之年,公司的幾個管理團隊對上市猶豫不決。

IPOF Stock Fails to Find a Target

IPOF股票找不到目標

Now, IPOF is set to return capital to its shareholders by Oct. 14, the deadline to find a target. Furthermore, it seems the hype around SPACs has cooled off. Palihapitiya isn't alone, though. More than 600 SPACs that hold a combined $174 billion are nearing deadlines to find a target over the next 16 months. These may find a fate similar to IPOF if no target is found.

現在,IPOF計劃在10月14日之前向股東返還資金,這是尋找收購目標的最後期限。此外,圍繞SPAC的炒作似乎已經降温。不過,帕裏哈皮蒂亞並不孤單。600多家SPAC總共持有1,740億美元,它們正在接近最後期限,希望在未來16個月找到目標。如果找不到目標,它們可能會發現類似於IPOF的命運。

On the other hand, the billionaire investor found success with some of his other SPACs. He successfully took companies like Opendoor (NASDAQ:OPEN), SoFi (NASDAQ:SOFI) and Clover Health (NASDAQ:CLOV) public. Still, all three of these companies are down by more than 40% year-to-date (YTD), with OPEN having the greatest YTD loss of 75%. The large losses on these former SPACs may have scared off potential targets of IPOF.

另一方面,這位億萬富翁投資者在他的一些其他SPAC上取得了成功。他成功地將像這樣的公司OpenDoor(納斯達克:開放),SOFI(納斯達克:SOFI)和三葉草健康(納斯達克:CLOV)公眾。儘管如此,這三家公司今年迄今的跌幅都超過了40%,其中Open的YTD跌幅最大,為75%。這些前SPAC的鉅額虧損可能嚇跑了IPOF的潛在目標。

Palihapitiya noted his opinion on SPACs has remained unchanged since his first deal was signed. He views them as "just one of many tools in our toolkit to support companies as they enter subsequent stages of growth."

Palihapitiya指出,自他簽署第一筆交易以來,他對SPAC的看法一直沒有改變。他認為它們只是“我們工具箱中支持公司進入後續成長階段的眾多工具之一。”

In the meantime, Palihapitiya will focus on targets for his two remaining Bio 2.0 SPACs. Four Bio 2.0 SPACs were launched, while two have already found targets in the form of ProKidney (NASDAQ:PROK) and Akili (NASDAQ:AKLI). In an earlier interview, he disclosed that Social Capital had made $750 million from SPACs, roughly doubling their initial investment.

與此同時,Palihapitiya將專注於他剩下的兩個Bio 2.0 SPAC的目標。發射了四個Bio 2.0空間委員會,其中兩個已經找到了以原腎(納斯達克:PROK)和阿基裏(納斯達克:阿克利)。在早些時候的一次採訪中,他透露社會資本從SPAC中獲得了7.5億美元,大約是他們最初投資的兩倍。

On the date of publication, Eddie Pan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

截至發稿之日,潘石屹並未(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點,以InvestorPlace.com為準出版指南.

Eddie Pan specializes in institutional investments and insider activity. He writes for InvestorPlace's Today's Market team, which centers on the latest news involving popular stocks.

埃迪·潘專門從事機構投資和內部活動。他為InvestorPlace的今日市場團隊撰稿,該團隊主要關注與熱門股票有關的最新消息。

The post Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here's Why. appeared first on InvestorPlace.

紅火的IPOF股票將於10月14日停止交易。原因如下。最先出現在InvestorPlace上。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論